ABP-102/CT-P72 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Three-year Bar rule reduced as Supreme Court creates new Civil Judge recruitment pathway

Telangana pharma factory explosion kills two workers and leaves two critically burned

Alvotech (Nasdaq: ALVO) lands $150m Lotus biosimilar deal across US, Asia

Irruptive Metals (TSXV: IRR) upsizes Pimentón financing to C$50m

Read More

Pharma Industry News

Abpro and Celltrion reveal promising preclinical results for ABP-102/CT-P72 at AACR 2025

Discover how Abpro and Celltrion’s ABP-102/CT-P72 could reshape HER2 cancer treatment with promising preclinical results. Read the full details now!

byPallavi Madhiraju

April 28, 2025

web analytics